Clinical hold on BioNTech malaria vaccine trial

 

BioNTech said in a regulatory filing on Tuesday the U.S. Food and Drug Administration has placed a clinical hold on an early-to-mid stage trial of. it malaria vaccine.

https://www.marketscreener.com/quote/stock/BIONTECH-SE-66771992/news/U-S-FDA-places-clinical-hold-on-BioNTech-s-malaria-vaccine-study-49235955/